Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Immune cell trafficking across the blood-brain barrier in the absence and presence of neuroinflammation
It disrupts your protocol timing, potentially requiring a restart of the current escalation phase if the gap extends beyond a week
ALA may lower blood sugar and interact with diabetes medications
In recent works, the study demonstrated that GCH1/ BH4 pathic enzyme dihydrofolate reductase (DHFR) could inhibit ferroptosis by generating BH4, so decrease in DHFR activity reduces BH4 content to enhance lipid peroxidation and sensitizes cells to ferroptosis (Lu et al., 2024), but the detail process is still unknown (Figure 1)
It is not for human consumption, medical use, therapeutic use, or veterinary use
What safety considerations should clinicians evaluate
